Prof. M. Youns

Prof. Dr. Prof. M. Youns

Professor of Biochemistry
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TNTamer Nasr
Tamer Nasr
SBSamir Bondock
Samir Bondock
PYProf. M. Youns
Prof. M. Youns

14 November 2010 in Cancer Research
Verified
Journal Article
Closed access
PDF file
PSPedro de Souza Rocha Simonini
Pedro de Souza Rocha Simonini
ABAchim Breiling
Achim Breiling
NGNibedita Gupta
Nibedita Gupta
MMMahdi Malekpour
Mahdi Malekpour
PYProf. M. Youns
Prof. M. Youns
YRYasser Riazalhosseini
Yasser Riazalhosseini
Estrogen receptor α (ERα) upregulation causes abnormal cell proliferation in about two thirds of breast cancers, yet understanding of the underlying mechanisms remains incomplete. Here, we show that high expression of the microRNA miR-375 in ERα-positive breast cell lines is a key driver of their proliferation. miR-375 overexpression was caused by loss of epigenetic marks including H3K9me2 and local DNA hypomethylation, dissociation of the transcriptional repressor CTCF from the miR-375 promoter, and interactions of ERα with regulatory regions of miR-375. Inhibiting miR-375 in ERα-positive MCF-7 cells resulted in reduced ERα activation and cell proliferation. A combination of expression profiling from tumor samples and miRNA target prediction identified RASD1 as a potential miR-375 target. Mechanistic investigations revealed that miR-375 regulates RASD1 by targeting the 3′ untranslated region in RASD1 mRNA. Additionally, we found that RASD1 negatively regulates ERα expression. Our findings define a forward feedback pathway in control of ERα expression, highlighting new strategies to treat ERα-positive invasive breast tumors. Cancer Res; 70(22); 9175–84. ©2010 AACR.

1 April 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KKKuete Kuete
Kuete Kuete
BKBenjamin Krusche
Benjamin Krusche
PYProf. M. Youns
Prof. M. Youns
IVIgor Voukeng
Igor Voukeng
AFAimé G. Fankam
Aimé G. Fankam
Thomas EfferthThomas Efferth
Thomas Efferth

1 July 2021 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
HAHany Attia
Hany Attia
YMYasmine Shafik Moemen
Yasmine Shafik Moemen
PYProf. M. Youns
Prof. M. Youns
AIAmmar M. Ibrahim
Ammar M. Ibrahim
RARanda Abdou
Randa Abdou
MRMohamed A. El Raey
Mohamed A. El Raey

21 July 2010 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
SMSri Mulyaningsih
Sri Mulyaningsih
PYProf. M. Youns
Prof. M. Youns
MEMahmoud Z El-Readi
Mahmoud Z El-Readi
Mohamed L. AshourMohamed L. Ashour
Mohamed L. Ashour
ENEndalkachew Nibret
Endalkachew Nibret
Michael WinkMichael Wink
Michael Wink
Objectives: The aim was to determine the chemical composition of the essential oil of Kadsura longipedunculata and the biological activity of the oil and its major components. Methods: The essential oil from stem bark of Kadsura longipedunculata was analysed by capillary gas chromatography (GLC/FID) and gas chromatography–mass spectrometry (GLC/MS). The ability of the oil to reduce diphenylpicrylhydrazine (DPPH•) was used to evaluate the antioxidant activity. Inhibition of both lipoxygenase and prostaglandin E2 was used to assess the anti-inflammatory activity. Antimicrobial activity was studied in vitro against a range of bacteria and fungi using diffusion and microdilution methods. Inhibition of trypanosome proliferation was assessed using resazurin as vital stain. The in-vitro cytotoxicity of the essential oil on six human cancer cell lines (HepG2, MIA PaCa-2, HeLa, HL-60, MDA-MB-231 and SW-480) was examined using the MTT assay. Key findings: Fifty compounds, representing 97.63% of total oil, were identified. δ-Cadinene (21.79%), camphene (7.27%), borneol (6.05%), cubenol (5.12%) and δ-cadinol (5.11%) were found to be the major components of the oil. The oil exerted a good antimicrobial activity against all Gram-positive bacteria tested, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. Streptococcus pyogenes and S. agalactiae were the most sensitive bacteria with a minimal inhibitory concentration (MIC) of 60 µg/ml oil. The essential oil showed a moderate fungicidal activity against yeasts, but it did not show any activity against Gram-negative bacteria. The essential oil showed a good trypanocidal activity in Trypanosoma b. brucei with an IC50 value of 50.52 ± 0.029 µg/ml. Radical scavenging activity had an IC50 value of 3.06 ± 0.79 mg/ml. 5-Lipoxygenase inhibition (IC50 = 38.58 µg/ml) and prostaglandin E2 production inhibition (28.82% at 25 µg/ml) accounted for anti-inflammatory activity of the oil. The oil exhibited some degree of cytotoxic activity against MIA PaCa-2, HepG-2 and SW-480 cell lines with IC50 values of 133.53, 136.96 and 136.62 µg/ml, respectively. The oil increased caspase 3/7 activity (an indicator of apoptosis) 2.5–4 fold in MIA Paca-2 cells. Camphene and borneol did not show antioxidant activity. However, both compounds exhibited some degree of antimicrobial, trypanocidal, anti-inflammatory and cytotoxic activity. Conclusions: This investigation provided evidence for, and confirmed the efficacy of, K. longipedunculata, a traditionally used Chinese medicinal plant for the treatment of inflammation and infection.

4 January 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PYProf. M. Youns
Prof. M. Youns
Wael HegazyWael Hegazy
Wael Hegazy
Digestive cancers are major causes of mortality and morbidity worldwide. Fisetin, a naturally occurring flavonoid, has been previously shown anti-proliferative, anti-cancer, neuroprotective, and antioxidant activities. In our study, the anti-tumor activities in addition to regulatory effects of fisetin on some cancer cell lines were investigated. Data presented here showed that fisetin induces growth inhibition, and apoptosis in hepatic (HepG-2), colorectal (Caco-2) and pancreatic (Suit-2) cancer cell lines. Gene expression results showed that 1307 genes were significantly regulated in their expression in hepatic and pancreatic cell lines. 350 genes were commonly up-regulated and 353 genes were commonly down-regulated. Additionally, 604 genes were oppositely expressed in both tumor cells. CDK5 signaling, NRF2-mediated oxidative stress response, glucocorticoid signaling, and ERK/MAPK signaling were among most prominent signaling pathways modulating the growth inhibitory effects of fisetin on hepatic and pancreatic cancer cells. The present analysis showed, for the first time, that the anti-tumor effect of fisetin was mediated mainly through modulation of multiple signaling pathways and via activation of CDKN1A, SEMA3E, GADD45B and GADD45A and down-regulation of TOP2A, KIF20A, CCNB2 and CCNB1 genes.